“IS IT SAFE AND COST SAVING TO DEFER THE CD4+ CELL COUNT MONITORING IN STABLE PATIENTS ON ART WITH MORE THAN 350 OR 500 CELLS µL?”. 2019. Mediterranean Journal of Hematology and Infectious Diseases 11 (1): e2019063. https://doi.org/10.4084/mjhid.2019.063.